Advanced search
Add to list

Purine nucleoside analogs as highly potent leads for the treatment of human African trypanosomiasis

Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Hulpia, Fabian, et al. “Purine Nucleoside Analogs as Highly Potent Leads for the Treatment of Human African Trypanosomiasis.” EFMC Young Medicinal Chemistry, 6th Symposium, Abstracts, 2019.
APA
Hulpia, F., Maes, L., de Koning, H. P., Caljon, G., & Van Calenbergh, S. (2019). Purine nucleoside analogs as highly potent leads for the treatment of human African trypanosomiasis. In EFMC Young Medicinal Chemistry, 6th Symposium, Abstracts. Athens, Greece.
Chicago author-date
Hulpia, Fabian, Louis Maes, Harry P. de Koning, Guy Caljon, and Serge Van Calenbergh. 2019. “Purine Nucleoside Analogs as Highly Potent Leads for the Treatment of Human African Trypanosomiasis.” In EFMC Young Medicinal Chemistry, 6th Symposium, Abstracts.
Chicago author-date (all authors)
Hulpia, Fabian, Louis Maes, Harry P. de Koning, Guy Caljon, and Serge Van Calenbergh. 2019. “Purine Nucleoside Analogs as Highly Potent Leads for the Treatment of Human African Trypanosomiasis.” In EFMC Young Medicinal Chemistry, 6th Symposium, Abstracts.
Vancouver
1.
Hulpia F, Maes L, de Koning HP, Caljon G, Van Calenbergh S. Purine nucleoside analogs as highly potent leads for the treatment of human African trypanosomiasis. In: EFMC Young Medicinal Chemistry, 6th Symposium, Abstracts. 2019.
IEEE
[1]
F. Hulpia, L. Maes, H. P. de Koning, G. Caljon, and S. Van Calenbergh, “Purine nucleoside analogs as highly potent leads for the treatment of human African trypanosomiasis,” in EFMC Young Medicinal Chemistry, 6th Symposium, Abstracts, Athens, Greece, 2019.
@inproceedings{8634818,
  author       = {Hulpia, Fabian and Maes, Louis and de Koning, Harry P. and Caljon, Guy and Van Calenbergh, Serge},
  booktitle    = {EFMC Young Medicinal Chemistry, 6th Symposium, Abstracts},
  language     = {eng},
  location     = {Athens, Greece},
  title        = {Purine nucleoside analogs as highly potent leads for the treatment of human African trypanosomiasis},
  year         = {2019},
}